导管相关血流感染市场(主要地区、市场参与者、规模和份额)-到 2031 年的预测

  • Report Code : TIPRE00029989
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Catheter-related Bloodstream Infections Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市场分析

导管相关的血流感染可能因导管尖端或外周静脉导管之间的菌血症而发生。这些与导管相关的血流感染是最致命、最频繁且成本最复杂的费用,因为医院对感染患者的维护费用很高。其原因是通过侵入性操作、不当或不受控制地使用抗生素以及不遵循称为“医院感染”(也称为医疗保健相关感染)的适当感染控制实践而获得的多重耐药病原体。血管内和外周 IV 导管是感染的原因。

增长驱动因素和挑战

驱动导管相关血流感染 (CRBSI) 市场增长的因素是血液感染的发生、侵入性医疗程序的增加以及先进设备的日益采用。侵入性手术通常需要使用导管,例如中心静脉导管、导尿管或透析导管,这些导管出于各种目的而插入体内。导管还为细菌和其他病原体提供了潜在的进入点,导致血液感染。侵入性医疗程序的兴起对推动导管相关血流感染市场产生了直接影响。对 CRBSI 风险的认识不断提高以及改善患者治疗效果的需求推动了感染预防策略的进步和创新产品的开发。随着医疗保健提供者和制造商共同努力减少 CRBSI 的发生率并提高侵入性手术中患者的安全,市场不断发展。因此,侵入性医疗程序数量的增加正在推动导管相关的血流感染市场的增长。

缺乏与医疗保健相关的感染监测系统,这些原因往往会导致识别此类感染的问题,因为制定统一的诊断标准非常具有挑战性。这些是导管相关血流感染市场的关键驱动因素和限制因素。

报告细分和范围

“2030 年全球导管相关血流感染市场分析”是一项专门且深入的研究,主要关注全球导管相关血流感染市场趋势和增长机会。该报告旨在概述全球导管相关血流感染市场,并按治疗类型、感染源、分销渠道和地理位置进行详细的市场细分。全球导管相关血流感染市场近年来一直在高速增长,预计在预测期内将继续这一趋势。该报告提供了全球导管相关血流感染使用情况的重要统计数据以及主要地区和国家的需求。此外,该报告还对影响主要地区和国家导管相关血流感染市场表现的各种因素进行了定性评估。该报告还对导管相关血流感染市场的领先企业及其关键战略发展进行了全面分析。还包括对市场动态的一些分析,以帮助确定关键驱动因素、市场趋势和利润丰厚的导管相关血流感染市场机会,从而有助于确定主要收入来源。

进一步、生态系统分析和波特五力分析提供了全球导管相关血流感染市场的 360 度视角。这有助于了解整个供应链以及影响市场增长的各种因素。

细分分析

全球导管相关血流感染市场根据治疗类型、感染源和分销渠道进行细分。根据治疗类型,导管相关血流感染市场分为抗微生物药物和抗生素封管治疗。根据感染源,市场分为凝固酶阴性葡萄球菌、金黄色葡萄球菌、肠革兰氏阴性杆菌、酵母菌、肠球菌和肠球菌。链球菌、假单胞菌等。导管相关血流感染市场根据分销渠道分为医院药房、零售药房和网上药房。

根据治疗类型,抗菌药物占据了重要的导管相关血流感染市场分享这可以归因于它在全球的受欢迎程度和广泛的可用性。不同类型的抗菌剂会引起血流感染,这些抗菌剂可抑制病原微生物在导管中定植并预防 CAUTI(导管相关性尿路感染)。然而,抗菌导管具有几个特征,例如,抗菌剂的释放、导管表面的变化、接触杀灭、生物膜形成的破坏以及利用细菌生物膜来防止病原体定植。尽管有这些特点,抗菌导管引起的尿路感染并没有减少。因此,由于上述原因,预计抗菌导管在与导管相关的血液感染中具有更高的市场份额。因此,抗微生物药物领域推动了导管相关血流感染市场份额的增长。

区域分析

该报告详细概述了全球导管相关血流感染市场涉及北美、欧洲、亚太地区(APAC)、中东和非洲(MEA)以及南美和非洲等五个主要地区。中美洲。由于血源性感染治疗技术的进步和强大的医疗基础设施,预计北美将在全球导管相关血流感染市场中占据重要份额,预计这一趋势将在预测期内盛行。越来越多的美国和加拿大导管血液感染患者(尤其是老年人)推动了北美市场的发展。

行业发展和未来机遇

合作、收购和新产品发布被认为是全球导管相关血流感染市场参与者采取的主要策略。

2020 年 2 月,CorMedix, Inc. 宣布 Neutrolin 获得美国食品和药物管理局的资助用于预防血液透析患者导管相关血流感染 (CRBSI) 的给药。

2023 年 4 月,Citius Pharmaceuticals, Inc. 成立,这是一家后期生物制药公司,致力于先导药物的开发和商业化级重症监护产品,宣布已推进 Mino-Lok 的临床试验,Mino-Lok 是一种抗生素封管溶液,用于挽救导管相关血流感染患者的导管。

新冠肺炎的影响/地缘政治情景的影响/经济衰退的影响

COVID-19 大流行极大地影响了导管相关血流感染的全球市场。由于对医疗资源的需求增加以及对医疗系统的巨大压力,CRBSI 带来了更高的风险。此外,控制感染的措施和增加 COVID-19 患者导管的使用也强化了对有效预防策略的需求。该分析提高了人们对流行病对市场影响的认识,并分析了在这些困难时期如何针对 CRBSI 风险采取行动。

竞争格局和主要公司

导管相关血流感染市场的一些主要参与者包括默克夏普公司和默克公司。 Dohme Corp、CorMedix, Inc.、Geistlich Pharma AG、辉瑞、Glenmark Pharmaceuticals Ltd.、Fresenius Medical Care、Taurophar GmbH、Citus Pharmaceuticals、AstraZeneca Pharma India Ltd.、Xellia Pharmaceuticals Ltd. 等。

Catheter-related Bloodstream Infections Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 治疗类型
  • 抗菌剂
  • 抗生素锁定疗法
By 感染源
  • 凝固酶阴性葡萄球菌
  • 金黄色葡萄球菌
  • 肠道革兰氏阴性杆菌
  • 酵母菌
  • 肠球菌和链球菌
  • 假单胞菌
  • 其他
By 分销渠道
  • 医院药房
  • 零售药房
  • 网上药房
By 地理
  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲和中美洲
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太地区其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Merck Sharp and Dohme Corp
  • CorMedix, Inc.
  • Geistlich Pharma AG
  • TauroPharm GmbH
  • Fresenius Medical Care
  • Pfizer
  • Glenmark Pharmaceuticals Ltd.
  • Citus Pharmaceuticals
  • AstraZeneca Pharma India Ltd.
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies
    1. Merck Sharp and Dohme Corp
    2. CorMedix, Inc.
    3. Geistlich Pharma AG
    4. TauroPharm GmbH
    5. Fresenius Medical Care
    6. Pfizer
    7. Glenmark Pharmaceuticals Ltd.
    8. Citus Pharmaceuticals
    9. AstraZeneca Pharma India Ltd.
    10. Xellia Pharmaceuticals Ltd.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports